Global and United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Report & Forecast 2023-2028

Report ID: 1719869 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction
    1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume for the Year 2017-2028
    1.3 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume for the Year 2017-2028
    1.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Dynamics
        1.5.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Trends
        1.5.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Drivers
        1.5.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Challenges
        1.5.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Segment by Type
        2.1.1 Pediatric Hepatitis B (CHO) Vaccine
        2.1.2 Adult Hepatitis B (CHO) Vaccine
    2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Type
        2.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Type
        2.3.1 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
    3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Application
        3.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Application
        3.3.1 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Competitor Landscape by Company
    4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Company
        4.1.1 Top Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturer (2017-2022)
        4.1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturer (2017-2022)
        4.1.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Manufacturer (2017-2022)
    4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Concentration Ratio (CR)
        4.2.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in 2021
        4.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturing Base Distribution, Product Type
        4.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Type
        4.3.3 Date of International Manufacturers Enter into Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Company
        4.5.1 Top Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Players (2020, 2021 & 2022)
5 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region
    5.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size in Volume by Region (2017-2028)
        5.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Region: 2017-2022
        5.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size in Value by Region (2017-2028)
        5.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Region: 2017-2022
        5.3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size YoY Growth 2017-2028
        6.1.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size YoY Growth 2017-2028
        6.3.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size YoY Growth 2017-2028
        6.4.2 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Merck & Co., Inc.
        7.1.1 Merck & Co., Inc. Corporation Information
        7.1.2 Merck & Co., Inc. Description and Business Overview
        7.1.3 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
        7.1.5 Merck & Co., Inc. Recent Development
    7.2 GlaxoSmithKline Plc
        7.2.1 GlaxoSmithKline Plc Corporation Information
        7.2.2 GlaxoSmithKline Plc Description and Business Overview
        7.2.3 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
        7.2.5 GlaxoSmithKline Plc Recent Development
    7.3 Pfizer Inc.
        7.3.1 Pfizer Inc. Corporation Information
        7.3.2 Pfizer Inc. Description and Business Overview
        7.3.3 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
        7.3.5 Pfizer Inc. Recent Development
    7.4 Sanofi Pasteur
        7.4.1 Sanofi Pasteur Corporation Information
        7.4.2 Sanofi Pasteur Description and Business Overview
        7.4.3 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
        7.4.5 Sanofi Pasteur Recent Development
    7.5 CSL Limited
        7.5.1 CSL Limited Corporation Information
        7.5.2 CSL Limited Description and Business Overview
        7.5.3 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
        7.5.5 CSL Limited Recent Development
    7.6 Emergent Biosolutions
        7.6.1 Emergent Biosolutions Corporation Information
        7.6.2 Emergent Biosolutions Description and Business Overview
        7.6.3 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
        7.6.5 Emergent Biosolutions Recent Development
    7.7 Serum Institute of India
        7.7.1 Serum Institute of India Corporation Information
        7.7.2 Serum Institute of India Description and Business Overview
        7.7.3 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
        7.7.5 Serum Institute of India Recent Development
    7.8 Johnson & Johnson
        7.8.1 Johnson & Johnson Corporation Information
        7.8.2 Johnson & Johnson Description and Business Overview
        7.8.3 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
        7.8.5 Johnson & Johnson Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Chain Analysis
    8.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors
    8.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Mode & Process
    8.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Marketing
        8.4.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Channels
        8.4.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors
    8.5 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer
List of Tables
    Table 1. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Trends
    Table 3. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Drivers
    Table 4. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Challenges
    Table 5. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Restraints
    Table 6. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturer, (K Doses), 2017-2022
    Table 14. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Manufacturer (2017-2022) & (USD/Dose)
    Table 16. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine as of 2021)
    Table 18. Top Players of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Type
    Table 20. Date of International Manufacturers Enter into Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Players, (K Doses), 2020, 2021 & 2022
    Table 26. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Region (2017-2022) & (K Doses)
    Table 29. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Doses)
    Table 30. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 33. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Region (2017-2028) & (K Doses)
    Table 35. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 37. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 39. Latin Americaa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 41. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Merck & Co., Inc. Corporation Information
    Table 43. Merck & Co., Inc. Description and Business Overview
    Table 44. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 45. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product
    Table 46. Merck & Co., Inc. Recent Development
    Table 47. GlaxoSmithKline Plc Corporation Information
    Table 48. GlaxoSmithKline Plc Description and Business Overview
    Table 49. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 50. GlaxoSmithKline Plc Product
    Table 51. GlaxoSmithKline Plc Recent Development
    Table 52. Pfizer Inc. Corporation Information
    Table 53. Pfizer Inc. Description and Business Overview
    Table 54. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 55. Pfizer Inc. Product
    Table 56. Pfizer Inc. Recent Development
    Table 57. Sanofi Pasteur Corporation Information
    Table 58. Sanofi Pasteur Description and Business Overview
    Table 59. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 60. Sanofi Pasteur Product
    Table 61. Sanofi Pasteur Recent Development
    Table 62. CSL Limited Corporation Information
    Table 63. CSL Limited Description and Business Overview
    Table 64. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 65. CSL Limited Product
    Table 66. CSL Limited Recent Development
    Table 67. Emergent Biosolutions Corporation Information
    Table 68. Emergent Biosolutions Description and Business Overview
    Table 69. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 70. Emergent Biosolutions Product
    Table 71. Emergent Biosolutions Recent Development
    Table 72. Serum Institute of India Corporation Information
    Table 73. Serum Institute of India Description and Business Overview
    Table 74. Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 75. Serum Institute of India Product
    Table 76. Serum Institute of India Recent Development
    Table 77. Johnson & Johnson Corporation Information
    Table 78. Johnson & Johnson Description and Business Overview
    Table 79. Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 80. Johnson & Johnson Product
    Table 81. Johnson & Johnson Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers List
    Table 85. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Picture
    Figure 2. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales 2017-2028 (K Doses)
    Figure 5. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales 2017-2028 (K Doses)
    Figure 8. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share in Global, in Volume (K Doses) 2017-2028
    Figure 10. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Report Years Considered
    Figure 11. Product Picture of Pediatric Hepatitis B (CHO) Vaccine
    Figure 12. Product Picture of Adult Hepatitis B (CHO) Vaccine
    Figure 13. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Type in 2022 & 2028
    Figure 14. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2017-2028) & (K Doses)
    Figure 17. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2017-2028) & (USD/Dose)
    Figure 19. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Type in 2022 & 2028
    Figure 20. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2017-2028) & (K Doses)
    Figure 23. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2017-2028) & (USD/Dose)
    Figure 25. Product Picture of Hospitals
    Figure 26. Product Picture of Clinics
    Figure 27. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Application in 2022 & 2028
    Figure 28. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2017-2028) & (K Doses)
    Figure 31. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2017-2028) & (USD/Dose)
    Figure 33. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Application in 2022 & 2028
    Figure 34. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2017-2028) & (K Doses)
    Figure 37. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2017-2028) & (USD/Dose)
    Figure 39. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 40. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 44. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 51. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 63. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 68. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. U.A.E Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Value Chain
    Figure 73. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck & Co., Inc.
GlaxoSmithKline Plc
Pfizer Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Serum Institute of India
Johnson & Johnson
Frequently Asked Questions
Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Remittance

Remittance market is segmented by region (country), players, by Type and by Application. Players, ... Read More